Press "Enter" to skip to content

Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies

FDA describes new policies to advance development of safe and effective cell and gene therapies

Also Read:   FDA sends warning to companies for offering unapproved umbilical cord blood products that may put patients at risk